The research noted that compared to free curcumin, the synthesized targeted drug reduces tumor volume in mice by inducing reactive oxygen species (ROS), cell cycle arrest, and regulating the NF-κB and Bax-mediated apoptotic pathways [40]. The gene discussed is NFKB1; the disease is neoplasm.